BioSpace News Archive

Press Releases

XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing

March 2, 2026
·
4 min read
Press Releases

Prothena Announces up to $100 Million Share Repurchase Plan

March 2, 2026
·
3 min read
Press Releases

Novocure to Participate in 2026 Leerink Global Healthcare Conference

March 2, 2026
·
2 min read
Press Releases

KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlier-Stage Renal Cell Carcinoma (RCC)

March 2, 2026
·
19 min read
Press Releases

WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma (RCC)

March 2, 2026
·
19 min read
Press Releases

Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting

March 2, 2026
·
7 min read
Press Releases

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting

March 2, 2026
·
8 min read
Press Releases

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib confirms its potential as first and only BTK inhibitor for relapsing and primary progressive MS in third positive Phase III study (FENhance 1)

March 2, 2026
·
9 min read
Press Releases

VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.

March 2, 2026
·
10 min read
Press Releases

Egle Therapeutics and Consortium Partners Awarded €8 Million Grant from Horizon Europe to Advance Clinical Development of EGL-001 in Neoadjuvant Head and Neck Cancer

March 2, 2026
·
4 min read